Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01480297Phase 2Completed
A Phase 2 trial of Amigesic in diabetic peripheral neuropathy (DPN), sponsored by University of Michigan. Started Nov 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01480297.